298 related articles for article (PubMed ID: 2437220)
1. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
Black RE; Levine MM; Clements ML; Losonsky G; Herrington D; Berman S; Formal SB
J Infect Dis; 1987 Jun; 155(6):1260-5. PubMed ID: 2437220
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
[TBL] [Abstract][Full Text] [Related]
3. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
Van de Verg L; Herrington DA; Murphy JR; Wasserman SS; Formal SB; Levine MM
Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813
[TBL] [Abstract][Full Text] [Related]
4. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
Herrington DA; Van de Verg L; Formal SB; Hale TL; Tall BD; Cryz SJ; Tramont EC; Levine MM
Vaccine; 1990 Aug; 8(4):353-7. PubMed ID: 2204243
[TBL] [Abstract][Full Text] [Related]
5. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
7. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.
Formal SB; Baron LS; Kopecko DJ; Washington O; Powell C; Life CA
Infect Immun; 1981 Dec; 34(3):746-50. PubMed ID: 6174449
[TBL] [Abstract][Full Text] [Related]
8. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
[TBL] [Abstract][Full Text] [Related]
9. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
10. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.
Cohen D; Ashkenazi S; Green MS; Gdalevich M; Robin G; Slepon R; Yavzori M; Orr N; Block C; Ashkenazi I; Shemer J; Taylor DN; Hale TL; Sadoff JC; Pavliakova D; Schneerson R; Robbins JB
Lancet; 1997 Jan; 349(9046):155-9. PubMed ID: 9111538
[TBL] [Abstract][Full Text] [Related]
11. Cell wall structures which may be important for successful immunization with Salmonella-Shigella hybrid vaccines.
Schultz CL; Kaufman B; Hamilton D; Hartman A; Ruiz M; Powell C; Berman S
Vaccine; 1990 Apr; 8(2):115-20. PubMed ID: 2159678
[TBL] [Abstract][Full Text] [Related]
12. Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.
Clarkson KA; Frenck RW; Dickey M; Suvarnapunya AE; Chandrasekaran L; Weerts HP; Heaney CD; McNeal M; Detizio K; Parker S; Hoeper A; Bourgeois AL; Porter CK; Venkatesan MM; Kaminski RW
mSphere; 2020 Sep; 5(5):. PubMed ID: 32968012
[No Abstract] [Full Text] [Related]
13. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
[TBL] [Abstract][Full Text] [Related]
14. Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.
Keren DF; Collins HH; Baron LS; Kopecko DJ; Formal SB
Infect Immun; 1982 Jul; 37(1):387-9. PubMed ID: 7049953
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
Xu DQ; Cisar JO; Ambulos N; Burr DH; Kopecko DJ
Infect Immun; 2002 Aug; 70(8):4414-23. PubMed ID: 12117952
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
17. Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.
Pitisuttithum P; Islam D; Chamnanchanunt S; Ruamsap N; Khantapura P; Kaewkungwal J; Kittitrakul C; Luvira V; Dhitavat J; Venkatesan MM; Mason CJ; Bodhidatta L
Clin Vaccine Immunol; 2016 Jul; 23(7):564-75. PubMed ID: 27146000
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain.
Hartman AB; Ruiz MM; Schultz CL
J Clin Microbiol; 1991 Jan; 29(1):27-32. PubMed ID: 1993762
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Oaks EV; Turbyfill KR
Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
[TBL] [Abstract][Full Text] [Related]
20. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.
Tacket CO; Forrest B; Morona R; Attridge SR; LaBrooy J; Tall BD; Reymann M; Rowley D; Levine MM
Infect Immun; 1990 Jun; 58(6):1620-7. PubMed ID: 1692807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
